YadavJSWholeyMHKuntzRE; Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493–1501.
2.
BrottTGHobsonRW2ndHowardGStenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11–23.
3.
WhiteCJ. Carotid artery stenting. J Am Coll Cardiol. 2014;64:722–731.
4.
EnomotoYYoshimuraS. Antiplatelet therapy for carotid artery stenting. Interv Neurol. 2013;1:151–163.
5.
LiuYShakurYYoshitakeMCilostazol (Pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake. Cardiovasc Drug Rev. 2001;19:369–386.
6.
WeintraubWS. The vascular effects of cilostazol. Can J Cardiol. 2006;22:56B–60B.
7.
ShinHKKimYKKimKYRemnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation. 2004;109:1022–1028.
8.
LeeHRShinHKParkSYCilostazol upregulates autophagy via SIRT1 activation: reducing amyloid-β peptide and APP-CTFβ levels in neuronal cells. PLoS One. 2015;10:e0134486.
9.
TsuchiyaTAshikagaKHondaTPrevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome. J Cardiovasc Electrophysiol. 2002;13:698–701.
10.
DawsonDLCutlerBSMeissnerMHCilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation. 1998;98:678–686.
11.
DawsonDLCutlerBSHiattWRA comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. 2000;109:523–530.
12.
BedenisRStewartMCleanthisMCilostazol for intermittent claudication. Cochrane Database Syst Rev. 2014;10:CD003748.
13.
TsuchikaneEFukuharaAKobayashiTImpact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Circulation. 1999;100:21–26.
14.
Biondi-ZoccaiGGLotrionteMAnselminoMSystematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention. Am Heart J. 2008;155:1081–1089.
15.
ChenJMengHXuLEfficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials. J Thromb Thrombolysis. 2015;39:23–34.
16.
GotohFTohgiHHiraiSCilostazol stroke prevention study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis. 2000;9:147–157.
17.
ShinoharaYKatayamaYUchiyamaS;CSPS 2 group. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol. 2010;9:959–968.
18.
UchiyamaSDemaerschalkBMGotoSStroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials. J Stroke Cerebrovasc Dis. 2009;18:482–490.
19.
KwonSUChoYJKooJSCilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke. 2005;36:782–786.
20.
WarnerCJGreavesSWLarsonRJCilostazol is associated with improved outcomes after peripheral endovascular interventions. J Vasc Surg. 2014;59:1607–1614.
21.
GalyfosGGeropapasGSigalaFMeta-analysis of studies evaluating the effect of cilostazol on major outcomes after carotid stenting. J Endovasc Ther. 2016;23:186–195.
22.
Biondi-ZoccaiG, ed. Umbrella Reviews. Evidence Synthesis With Overviews of Reviews and Meta-Epidemiologic Studies. Cham, Switzerland: Springer International; 2016.
23.
IoannidisJPTrikalinosTA. An exploratory test for an excess of significant findings. Clin Trials. 2007;4:245–253.
24.
Biondi-ZoccaiG, ed. Network Meta-Analysis: Evidence Synthesis With Mixed Treatment Comparison. Hauppauge, NY: Nova Science; 2014.
